AnxietyNCT07234006
Neurofeedback-mindfulness Techniques on Anxiety, Stress, and Academic Performance of Nursing Students
A study testing NEUROFEEDBACK-MINDFULNESS in people with Anxiety and Stress, run by University of Salamanca at 1 site in Spain.
Trial summary
In today's society, anxiety and stress are prevalent emotional responses in mental health globally, significantly affecting students' well-being and academic performance. In particular, undergraduate nursing students face high levels of these problems due to the heavy academic workload and demands of their training… Read more about this study
- Who is it for?
- Ages 18 to 45 yearsHealthy volunteers can take part
- Conditions the study is for
- Anxiety, Stress, Academic Performance
- What is being tested?
- NEUROFEEDBACK-MINDFULNESS
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 siteSpain
- Study dates
- 21 Nov 2025to 31 May 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Students enrolled in the nursing degree at the University of Salamanca
- Aged between 18 and 45 years
- Willing to voluntarily participate in the study and sign the informed consent form.
Who cannot join
- History of serious psychiatric disorders in the 6 months prior to inclusion in the study.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Spain1 site, 1 recruiting
- Recruiting
Faculty of Nursing
Salamanca
Jose I Recio-Rodriguez, 650330694
About this study
Official title: EFFECT OF NEUROFEEDBACK-MINDFULNESS TECHNIQUES ON ANXIETY, STRESS, AND ACADEMIC PERFORMANCE OF NURSING STUDENTS
In today's society, anxiety and stress are prevalent emotional responses in mental health globally, significantly affecting students' well-being and academic performance. In particular, undergraduate nursing students face high levels of these problems due to the heavy academic workload and demands of their training, especially during exam periods. The need for concentration, emotional management, and decision-making under pressure contribute to the prevalence of these disorders, impacting both their quality of life and academic performance.
Despite the existence of multiple strategies and techniques for managing these issues, it is still necessary to continue exploring innovative alternatives that complement traditional interventions. For this reason, this project aims to evaluate the effectiveness of mindfulness-neurofeedback as a treatment to reduce stress and anxiety in nursing students, with the goal of providing scientific evidence on this intervention. This brain training technique is presented as a promising option, based on the modulation of brain activity, with the potential to improve emotional regulation and concentration in the educational setting.
- Conditions
- Anxiety, Stress, Academic Performance
- Being tested
- NEUROFEEDBACK-MINDFULNESS, No intervention
- Medical subject headings
- Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
NEUROFEEDBACK-MINDFULNESSBehavioural
The Neurofeedback-Assisted Mindfulness Training sessions will be given to the intervention group participants after randomization. Each session will vary in length depending on the session, but will last a maximum of 20 minutes.
A total of 20 sessions will be held at the participant's home, preferably in the afternoon, at a rate of 5 sessions per week for 4 weeks after randomization. The organization of the sessions is described in the following table of this study's protocol.
No interventionOther
No intervention
| Study group | Role | What they receive |
|---|---|---|
| No intervention | Other | No intervention Receives: Other: No intervention |
| NEUROFEEDBACK-MINDFULNESS | Experimental | Neurofeedback-Assisted Mindfulness Training Program Receives: Behavioral: NEUROFEEDBACK-MINDFULNESS |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from Baseline in the Mean of the Depression, anxiety and stress scale at 4 weeks
Zero is equivalent to no symptoms and 63 indicates the worst possible symptoms
Measured: From enrollment to the end of treatment at 4 weeks
Change from Baseline in the Mean Academic performance score at 4 weeks
Zero is equivalent to the best academic performance and 40 indicates the worst academic performance
Measured: From enrollment to the end of treatment at 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Nov 2025
- Study start21 Nov 2025
- Primary completion28 Feb 2026 (estimated)
- Study completion31 May 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AnxietyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 36 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Salamanca
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, José Ignacio Recio Rodriguez, University of Salamanca
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07234006
- Sponsor's protocol ID
- IBYP25/034
- Status last verified
- Feb 2026
- First submitted
- 14 Nov 2025
- Last updated
- 9 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- EFFECT OF NEUROFEEDBACK-MINDFULNESS TECHNIQUES ON ANXIETY, STRESS, AND ACADEMIC PERFORMANCE OF NURSING STUDENTS
- ClinicalTrials.gov ID
- NCT07234006
- Acronym / sponsor ID
- IBYP25/034
- Conditions
- Anxiety, Stress, Academic Performance
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 36 participants (estimated)
- Lead sponsor
- University of SalamancaUniversity, hospital or other
- Study start
- 21 Nov 2025 (actual)
- Primary completion
- 28 Feb 2026 (estimated)
- Study completion
- 31 May 2026 (estimated)
- First posted
- 18 Nov 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In today's society, anxiety and stress are prevalent emotional responses in mental health globally, significantly affecting students' well-being and academic performance. In particular, undergraduate nursing students face high levels of these problems due to the heavy academic workload and demands of their training, especially during exam periods. The need for concentration, emotional management, and decision-making under pressure contribute to the prevalence of these disorders, impacting both their quality of life and academic performance.
Despite the existence of multiple strategies and techniques for managing these issues, it is still necessary to continue exploring innovative alternatives that complement traditional interventions. For this reason, this project aims to evaluate the effectiveness of mindfulness-neurofeedback as a treatment to reduce stress and anxiety in nursing students, with the goal of providing scientific evidence on this intervention. This brain training technique is presented as a promising option, based on the modulation of brain activity, with the potential to improve emotional regulation and concentration in the educational setting.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| No intervention | Other | Other: No interventionNo intervention |
| NEUROFEEDBACK-MINDFULNESS | Experimental | Behavioral: NEUROFEEDBACK-MINDFULNESSNeurofeedback-Assisted Mindfulness Training Program |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Students enrolled in the nursing degree at the University of Salamanca
- Aged between 18 and 45 years
- Willing to voluntarily participate in the study and sign the informed consent form.
Key exclusion criteria (1 listed)
- History of serious psychiatric disorders in the 6 months prior to inclusion in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| NEUROFEEDBACK-MINDFULNESSThe Neurofeedback-Assisted Mindfulness Training sessions will be given to the intervention group participants after randomization. Each session will vary in length depending on the session, but will last a maximum of 20 minutes. A total of 20 sessions will be held at the participant's home, preferably in the afternoon, at a rate of 5 sessions per week for 4 weeks after randomization. The organization of the sessions is described in the following table of this study's protocol. | Behavioural | NEUROFEEDBACK-MINDFULNESS |
| No interventionNo intervention | Other | No intervention |
Primary outcome
Change from Baseline in the Mean of the Depression, anxiety and stress scale at 4 weeks
Time frame: From enrollment to the end of treatment at 4 weeks
Zero is equivalent to no symptoms and 63 indicates the worst possible symptoms
Change from Baseline in the Mean Academic performance score at 4 weeks
Time frame: From enrollment to the end of treatment at 4 weeks
Zero is equivalent to the best academic performance and 40 indicates the worst academic performance
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Anxiety
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Recruiting
Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)
Mental Health and General Well-being
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing NEUROFEEDBACK-MINDFULNESS in people with Anxiety and Stress, run by University of Salamanca at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 9 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact José Ignacio Recio Rodriguez, Doctor (+34650330694, donrecio@usal.es), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from Baseline in the Mean of the Depression, anxiety and stress scale at 4 weeks (time frame: From enrollment to the end of treatment at 4 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2026.